This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kind Pharmaceutical. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Haohao Wu: Innovator in Indolizine Derivatives
Introduction
Haohao Wu is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on indolizine derivatives. With a total of 4 patents to his name, Wu's innovations are paving the way for advancements in medical applications.
Latest Patents
Wu's latest patents focus on indolizine derivatives and their application in medicine. These inventions disclose novel substituted indolizine derivatives, which can include isotopically labeled compounds, optical isomers, geometric isomers, tautomers, or mixtures of various isomers. Additionally, these compounds can be presented as pharmaceutically acceptable salts or prodrugs. The significance of these inventions lies in their potential use in medical treatments, showcasing Wu's commitment to advancing healthcare through innovative chemistry.
Career Highlights
Haohao Wu is currently associated with Kind Pharmaceutical, where he continues to develop his research and inventions. His work has garnered attention in the pharmaceutical industry, contributing to the development of new therapeutic agents.
Collaborations
Wu collaborates with notable colleagues, including Dong Liu and Dongdong Chen. These partnerships enhance the research and development efforts within his field, fostering innovation and creativity.
Conclusion
Haohao Wu's contributions to the field of medicinal chemistry, particularly through his work on indolizine derivatives, highlight his role as a key innovator. His patents not only reflect his expertise but also promise advancements in medical applications that could benefit many.